- •Preface
- •Acknowledgments
- •Contents
- •1.1 Introduction
- •1.2 Normal Embryology
- •1.3 Abnormalities of the Kidney
- •1.3.1 Renal Agenesis
- •1.3.2 Renal Hypoplasia
- •1.3.3 Supernumerary Kidneys
- •1.3.5 Polycystic Kidney Disease
- •1.3.6 Simple (Solitary) Renal Cyst
- •1.3.7 Renal Fusion and Renal Ectopia
- •1.3.8 Horseshoe Kidney
- •1.3.9 Crossed Fused Renal Ectopia
- •1.4 Abnormalities of the Ureter
- •1.5 Abnormalities of the Bladder
- •1.6 Abnormalities of the Penis and Urethra in Males
- •1.7 Abnormalities of Female External Genitalia
- •Further Reading
- •2.1 Introduction
- •2.2 Pathophysiology
- •2.3 Etiology of Hydronephrosis
- •2.5 Clinical Features
- •2.6 Investigations and Diagnosis
- •2.7 Treatment
- •2.8 Antenatal Hydronephrosis
- •Further Reading
- •3.1 Introduction
- •3.2 Embryology
- •3.3 Pathophysiology
- •3.4 Etiology of PUJ Obstruction
- •3.5 Clinical Features
- •3.6 Diagnosis and Investigations
- •3.7 Management of Newborns with PUJ Obstruction
- •3.8 Treatment
- •3.9 Post-operative Complications and Follow-Up
- •Further Reading
- •4: Renal Tumors in Children
- •4.1 Introduction
- •4.2 Wilms’ Tumor
- •4.2.1 Introduction
- •4.2.2 Etiology
- •4.2.3 Histopathology
- •4.2.4 Nephroblastomatosis
- •4.2.5 Clinical Features
- •4.2.6 Risk Factors for Wilms’ Tumor
- •4.2.7 Staging of Wilms Tumor
- •4.2.8 Investigations
- •4.2.9 Prognosis and Complications of Wilms Tumor
- •4.2.10 Surgical Considerations
- •4.2.11 Surgical Complications
- •4.2.12 Prognosis and Outcome
- •4.2.13 Extrarenal Wilms’ Tumors
- •4.3 Mesoblastic Nephroma
- •4.3.1 Introduction
- •4.3.3 Epidemiology
- •4.3.5 Clinical Features
- •4.3.6 Investigations
- •4.3.7 Treatment and Prognosis
- •4.4 Clear Cell Sarcoma of the Kidney (CCSK)
- •4.4.1 Introduction
- •4.4.2 Pathophysiology
- •4.4.3 Clinical Features
- •4.4.4 Investigations
- •4.4.5 Histopathology
- •4.4.6 Treatment
- •4.4.7 Prognosis
- •4.5 Malignant Rhabdoid Tumor of the Kidney
- •4.5.1 Introduction
- •4.5.2 Etiology and Pathophysiology
- •4.5.3 Histologic Findings
- •4.5.4 Clinical Features
- •4.5.5 Investigations and Diagnosis
- •4.5.6 Treatment and Outcome
- •4.5.7 Mortality/Morbidity
- •4.6 Renal Cell Carcinoma in Children
- •4.6.1 Introduction
- •4.6.2 Histopathology
- •4.6.4 Staging
- •4.6.5 Clinical Features
- •4.6.6 Investigations
- •4.6.7 Management
- •4.6.8 Prognosis
- •4.7 Angiomyolipoma of the Kidney
- •4.7.1 Introduction
- •4.7.2 Histopathology
- •4.7.4 Clinical Features
- •4.7.5 Investigations
- •4.7.6 Treatment and Prognosis
- •4.8 Renal Lymphoma
- •4.8.1 Introduction
- •4.8.2 Etiology and Pathogenesis
- •4.8.3 Diagnosis
- •4.8.4 Clinical Features
- •4.8.5 Treatment and Prognosis
- •4.9 Ossifying Renal Tumor of Infancy
- •4.10 Metanephric Adenoma
- •4.10.1 Introduction
- •4.10.2 Histopathology
- •4.10.3 Diagnosis
- •4.10.4 Clinical Features
- •4.10.5 Treatment
- •4.11 Multilocular Cystic Renal Tumor
- •Further Reading
- •Wilms’ Tumor
- •Mesoblastic Nephroma
- •Renal Cell Carcinoma in Children
- •Angiomyolipoma of the Kidney
- •Renal Lymphoma
- •Ossifying Renal Tumor of Infancy
- •Metanephric Adenoma
- •Multilocular Cystic Renal Tumor
- •5.1 Introduction
- •5.2 Embryology
- •5.4 Histologic Findings
- •5.7 Associated Anomalies
- •5.8 Clinical Features
- •5.9 Investigations
- •5.10 Treatment
- •Further Reading
- •6: Congenital Ureteral Anomalies
- •6.1 Etiology
- •6.2 Clinical Features
- •6.3 Investigations and Diagnosis
- •6.4 Duplex (Duplicated) System
- •6.4.1 Introduction
- •6.4.3 Clinical Features
- •6.4.4 Investigations
- •6.4.5 Treatment and Prognosis
- •6.5 Ectopic Ureter
- •6.5.1 Introduction
- •6.5.3 Clinical Features
- •6.5.4 Diagnosis
- •6.5.5 Surgical Treatment
- •6.6 Ureterocele
- •6.6.1 Introduction
- •6.6.3 Clinical Features
- •6.6.4 Investigations and Diagnosis
- •6.6.5 Treatment
- •6.6.5.1 Surgical Interventions
- •6.8 Mega Ureter
- •Further Reading
- •7: Congenital Megaureter
- •7.1 Introduction
- •7.3 Etiology and Pathophysiology
- •7.4 Clinical Presentation
- •7.5 Investigations and Diagnosis
- •7.6 Treatment and Prognosis
- •7.7 Complications
- •Further Reading
- •8.1 Introduction
- •8.2 Pathophysiology
- •8.4 Etiology of VUR
- •8.5 Clinical Features
- •8.6 Investigations
- •8.7 Management
- •8.7.1 Medical Treatment of VUR
- •8.7.2 Antibiotics Used for Prophylaxis
- •8.7.3 Anticholinergics
- •8.7.4 Surveillance
- •8.8 Surgical Therapy of VUR
- •8.8.1 Indications for Surgical Interventions
- •8.8.2 Indications for Surgical Interventions Based on Age at Diagnosis and the Presence or Absence of Renal Lesions
- •8.8.3 Endoscopic Injection
- •8.8.4 Surgical Management
- •8.9 Mortality/Morbidity
- •Further Reading
- •9: Pediatric Urolithiasis
- •9.1 Introduction
- •9.2 Etiology
- •9.4 Clinical Features
- •9.5 Investigations
- •9.6 Complications of Urolithiasis
- •9.7 Management
- •Further Reading
- •10.1 Introduction
- •10.2 Embryology of Persistent Müllerian Duct Syndrome
- •10.3 Etiology and Inheritance of PMDS
- •10.5 Clinical Features
- •10.6 Treatment
- •10.7 Prognosis
- •Further Reading
- •11.1 Introduction
- •11.2 Physiology and Bladder Function
- •11.2.1 Micturition
- •11.3 Pathophysiological Changes of NBSD
- •11.4 Etiology and Clinical Features
- •11.5 Investigations and Diagnosis
- •11.7 Management
- •11.8 Clean Intermittent Catheterization
- •11.9 Anticholinergics
- •11.10 Botulinum Toxin Type A
- •11.11 Tricyclic Antidepressant Drugs
- •11.12 Surgical Management
- •Further Reading
- •12.1 Introduction
- •12.2 Etiology
- •12.3 Pathophysiology
- •12.4 Clinical Features
- •12.5 Investigations and Diagnosis
- •12.6 Management
- •Further Reading
- •13.1 Introduction
- •13.2 Embryology
- •13.3 Epispadias
- •13.3.1 Introduction
- •13.3.2 Etiology
- •13.3.4 Treatment
- •13.3.6 Female Epispadias
- •13.3.7 Surgical Repair of Female Epispadias
- •13.3.8 Prognosis
- •13.4 Bladder Exstrophy
- •13.4.1 Introduction
- •13.4.2 Associated Anomalies
- •13.4.3 Principles of Surgical Management of Bladder Exstrophy
- •13.4.4 Evaluation and Management
- •13.5 Cloacal Exstrophy
- •13.5.1 Introduction
- •13.5.2 Skeletal Changes in Cloacal Exstrophy
- •13.5.3 Etiology and Pathogenesis
- •13.5.4 Prenatal Diagnosis
- •13.5.5 Associated Anomalies
- •13.5.8 Surgical Reconstruction
- •13.5.9 Management of Urinary Incontinence
- •13.5.10 Prognosis
- •13.5.11 Complications
- •Further Reading
- •14.1 Introduction
- •14.2 Etiology
- •14.3 Clinical Features
- •14.4 Associated Anomalies
- •14.5 Diagnosis
- •14.6 Treatment and Prognosis
- •Further Reading
- •15: Cloacal Anomalies
- •15.1 Introduction
- •15.2 Associated Anomalies
- •15.4 Clinical Features
- •15.5 Investigations
- •Further Reading
- •16: Urachal Remnants
- •16.1 Introduction
- •16.2 Embryology
- •16.4 Clinical Features
- •16.5 Tumors and Urachal Remnants
- •16.6 Management
- •Further Reading
- •17: Inguinal Hernias and Hydroceles
- •17.1 Introduction
- •17.2 Inguinal Hernia
- •17.2.1 Incidence
- •17.2.2 Etiology
- •17.2.3 Clinical Features
- •17.2.4 Variants of Hernia
- •17.2.6 Treatment
- •17.2.7 Complications of Inguinal Herniotomy
- •17.3 Hydrocele
- •17.3.1 Embryology
- •17.3.3 Treatment
- •Further Reading
- •18: Cloacal Exstrophy
- •18.1 Introduction
- •18.2 Etiology and Pathogenesis
- •18.3 Associated Anomalies
- •18.4 Clinical Features and Management
- •Further Reading
- •19: Posterior Urethral Valve
- •19.1 Introduction
- •19.2 Embryology
- •19.3 Pathophysiology
- •19.5 Clinical Features
- •19.6 Investigations and Diagnosis
- •19.7 Management
- •19.8 Medications Used in Patients with PUV
- •19.10 Long-Term Outcomes
- •19.10.3 Bladder Dysfunction
- •19.10.4 Renal Transplantation
- •19.10.5 Fertility
- •Further Reading
- •20.1 Introduction
- •20.2 Embryology
- •20.4 Clinical Features
- •20.5 Investigations
- •20.6 Treatment
- •20.7 The Müllerian Duct Cyst
- •Further Reading
- •21: Hypospadias
- •21.1 Introduction
- •21.2 Effects of Hypospadias
- •21.3 Embryology
- •21.4 Etiology of Hypospadias
- •21.5 Associated Anomalies
- •21.7 Clinical Features of Hypospadias
- •21.8 Treatment
- •21.9 Urinary Diversion
- •21.10 Postoperative Complications
- •Further Reading
- •22: Male Circumcision
- •22.1 Introduction
- •22.2 Anatomy and Pathophysiology
- •22.3 History of Circumcision
- •22.4 Pain Management
- •22.5 Indications for Circumcision
- •22.6 Contraindications to Circumcision
- •22.7 Surgical Procedure
- •22.8 Complications of Circumcision
- •Further Reading
- •23: Priapism in Children
- •23.1 Introduction
- •23.2 Pathophysiology
- •23.3 Etiology
- •23.5 Clinical Features
- •23.6 Investigations
- •23.7 Management
- •23.8 Prognosis
- •23.9 Priapism and Sickle Cell Disease
- •23.9.1 Introduction
- •23.9.2 Epidemiology
- •23.9.4 Pathophysiology
- •23.9.5 Clinical Features
- •23.9.6 Treatment
- •23.9.7 Prevention of Stuttering Priapism
- •23.9.8 Complications of Priapism and Prognosis
- •Further Reading
- •24.1 Introduction
- •24.2 Embryology and Normal Testicular Development and Descent
- •24.4 Causes of Undescended Testes and Risk Factors
- •24.5 Histopathology
- •24.7 Clinical Features and Diagnosis
- •24.8 Treatment
- •24.8.1 Success of Surgical Treatment
- •24.9 Complications of Orchidopexy
- •24.10 Infertility and Undescended Testes
- •24.11 Undescended Testes and the Risk of Cancer
- •Further Reading
- •25: Varicocele
- •25.1 Introduction
- •25.2 Etiology
- •25.3 Pathophysiology
- •25.4 Grading of Varicoceles
- •25.5 Clinical Features
- •25.6 Diagnosis
- •25.7 Treatment
- •25.8 Postoperative Complications
- •25.9 Prognosis
- •Further Reading
- •26.1 Introduction
- •26.2 Etiology and Risk Factors
- •26.3 Diagnosis
- •26.4 Intermittent Testicular Torsion
- •26.6 Effects of Testicular Torsion
- •26.7 Clinical Features
- •26.8 Treatment
- •26.9.1 Introduction
- •26.9.2 Etiology of Extravaginal Torsion
- •26.9.3 Clinical Features
- •26.9.4 Treatment
- •26.10 Torsion of the Testicular or Epididymal Appendage
- •26.10.1 Introduction
- •26.10.2 Embryology
- •26.10.3 Clinical Features
- •26.10.4 Investigations and Treatment
- •Further Reading
- •27: Testicular Tumors in Children
- •27.1 Introduction
- •27.4 Etiology of Testicular Tumors
- •27.5 Clinical Features
- •27.6 Staging
- •27.6.1 Regional Lymph Node Staging
- •27.7 Investigations
- •27.8 Treatment
- •27.9 Yolk Sac Tumor
- •27.10 Teratoma
- •27.11 Mixed Germ Cell Tumor
- •27.12 Stromal Tumors
- •27.13 Simple Testicular Cyst
- •27.14 Epidermoid Cysts
- •27.15 Testicular Microlithiasis (TM)
- •27.16 Gonadoblastoma
- •27.17 Cystic Dysplasia of the Testes
- •27.18 Leukemia and Lymphoma
- •27.19 Paratesticular Rhabdomyosarcoma
- •27.20 Prognosis and Outcome
- •Further Reading
- •28: Splenogonadal Fusion
- •28.1 Introduction
- •28.2 Etiology
- •28.4 Associated Anomalies
- •28.5 Clinical Features
- •28.6 Investigations
- •28.7 Treatment
- •Further Reading
- •29: Acute Scrotum
- •29.1 Introduction
- •29.2 Torsion of Testes
- •29.2.1 Introduction
- •29.2.3 Etiology
- •29.2.4 Clinical Features
- •29.2.5 Effects of Torsion of Testes
- •29.2.6 Investigations
- •29.2.7 Treatment
- •29.3 Torsion of the Testicular or Epididymal Appendage
- •29.3.1 Introduction
- •29.3.2 Embryology
- •29.3.3 Clinical Features
- •29.3.4 Investigations and Treatment
- •29.4.1 Introduction
- •29.4.2 Etiology
- •29.4.3 Clinical Features
- •29.4.4 Investigations and Treatment
- •29.5 Idiopathic Scrotal Edema
- •29.6 Testicular Trauma
- •29.7 Other Causes of Acute Scrotum
- •29.8 Splenogonadal Fusion
- •Further Reading
- •30.1 Introduction
- •30.2 Imperforate Hymen
- •30.3 Vaginal Atresia
- •30.5 Associated Anomalies
- •30.6 Embryology
- •30.7 Clinical Features
- •30.8 Investigations
- •30.9 Management
- •Further Reading
- •31: Disorders of Sexual Development
- •31.1 Introduction
- •31.2 Embryology
- •31.3 Sexual and Gonadal Differentiation
- •31.5 Evaluation of a Newborn with DSD
- •31.6 Diagnosis and Investigations
- •31.7 Management of Patients with DSD
- •31.8 Surgical Corrections of DSD
- •31.9 Congenital Adrenal Hyperplasia (CAH)
- •31.10 Androgen Insensitivity Syndrome (Testicular Feminization Syndrome)
- •31.13 Gonadal Dysgenesis
- •31.15 Ovotestis Disorders of Sexual Development
- •31.16 Other Rare Disorders of Sexual Development
- •Further Reading
- •Index
6.4 Duplex (Duplicated) System |
193 |
|
|
•Two pelvicalyceal systems join at the ureteropelvic junction (bifid pelvis), or two ureters join before draining into the urinary bladder (bifid ureters).
–Double/duplicated ureters (or collecting system):
•This is characterized by two ureters that drain separately into the bladder or genital tract.
•Two ureters open separately into the renal pelvis superiorly and drain separately into the bladder or genital tract.
•Upper and lower pole ureters drain a duplex kidney’s upper and lower poles, respectively.
•As a result of these anatomic abnormalities:
–The duplicated ureters may be seen extending a variable distance down to the urinary bladder.
–Obstruction of the upper pole moiety down to the bladder may be seen, often associated with a ureterocoele.
–Vesicoureteral reflux into the lower pole moiety may be seen. This is often due to distortion in its insertion by an associated ureterocoele.
–Ectopic insertion of the upper pole moiety e.g. into the prostatic urethra in males or vaginal vault in females.
–If reflux is significant, evidence of reflux nephropathy may be evident.
6.4.3Clinical Features
•Most duplicated systems are asymptomatic and diagnosed incidentally.
•Duplex collecting system may be complicated by infection, vesicoureteral reflux or obstruction.
•Occasionally, hydronephrosis can be severe enough to result in flank discomfort, pain or even a palpable mass.
Classification of Duplex Collecting System
•Duplex kidney: Two separate pelvicalyceal system draining a single renal parenchyma.
•Duplex collecting system: A duplex kidney draining into:
–A single ureter: Duplex kidney with pelvicalyceal system uniting at the pelviureteric junction.
–Bifid ureters: Two ureters that unite before emptying into the urinary bladder.
–Double ureters (Complete duplication)
•Bifid collecting system: A duplex kidney with the two separate pelvicalyceal collecting system uniting at the pelviureteric junction or as bifid ureters (Incomplete ureteral duplication).
•Double/Duplicated ureters: Two ureters that drain separately into the urinary bladder or genital tract (Complete ureteral duplication).
•These are seen in patients with completely duplicated ureters.
•Duplication can be variable.
•At one end of the spectrum, there is merely a duplication of the renal pelvis, draining via a single ureter.
•At the other extreme, two separate collecting systems drain independently into the bladder or ectopically.
•Duplex systems may be unilateral or bilateral and can be associated with a variety of other congenital abnormalities of the urinary tract.
•Duplex systems can be associated with Fanconi anemia.
6.4.4Investigations
•Intravenous urography (IVU) (Figs. 6.14 and 6.15):
–This can demonstrate both collecting systems, but a poorly functioning system may not excrete contrast and will not be visualized.
–In such a situation, the functioning lower pole moiety will be inferiorly displaced,
194 |
6 Congenital Ureteral Anomalies |
|
|
Figs. 6.14 and 6.15 Intravenous urography showing partial (incomplete) ureteral duplication on the right side
taking on the so-called “drooping lily appearance”.
–This may be confused with an upper pole mass or cyst.
–A patient’s duplex kidney is usually longer than his/her nonduplex kidney.
–The parenchymal thickness of one of the poles of the duplex kidney is less than that of the other pole.
–The calyces are asymmetric
–An ectopic, upper pole ureteric insertion can produce a nonopacified segment. This mass effect results in the “drooping lily” sign with the depression of the lower pole pelvicaliceal system.
–If the lower pole of the duplex kidney is functioning poorly or not at all, the lower pole collecting system may not opacify, and no discernible parenchyma will surround it (nubbin sign). The kidney’s appearance may consequently resemble that of a nonduplex kidney with a lower polar mass or renal infarct.
–A reduction in the number of calyces, the depiction of a portion of the collecting
system, and the presence of a straight inferior border help to differentiate a duplex collecting system from a renal mass.
–Anomalies of the ureter, such as partial or complete ureteral duplication, may be demonstrated.
•Abdominal and pelvic ultrasound:
–Ultrasound is useful when the duplex system is associated with obstruction/ hydronephrosis.
–Ultrasound is also useful in detecting associated ureterocele.
–With the use of ultrasound it may be difficult to differentiate between partial and complete duplication.
–The duplex kidney appears as two central echo complexes with intervening renal parenchyma.
–Hydronephrosis at one pole is suggestive of a duplex kidney.
–Although hydronephrosis can occur at either pole, it is more common in the upper pole.
–Occasionally, two distinct collecting systems and ureters can be observed on ultrasonographic images.
6.4 Duplex (Duplicated) System |
195 |
|
|
–Differentiating an atrophied lower pole moiety of a duplex kidney (nubbin) from other renal masses is difficult.
–The nubbin of tissue from the atrophied lower pole of a duplex kidney cannot be confidently differentiated from other masses.
•CT urography:
–CT urography is able to delineate essentially all duplex abnormalities especially if reconstruction images are made.
–The intervening renal parenchyma in a duplex kidney lacks a collecting system and major vessels, and because of this it is described as having a “faceless kidney” appearance.
–A duplicated renal collecting system can be suspected if a faceless kidney is identified.
–CT scan can help to determine if an obstruction exists and can aid in assessing the renal parenchyma thickness.
–CT scan can also help to determine if the insertion of the duplex ureter is intravesical or extravesical.
–CT scan can demonstrate the collecting system in the nubbin or the mass effect of tissue at the pole.
–CT scan is superior to ultrasonography and excretory urography in diagnosing the lower pole nubbin.
•Nuclear scan:
–Renal scintigraphy is useful to evaluate renal function, particularly when planning corrective surgery.
–Renal scintigraphy is less useful to identify non-obstructed duplex systems.
–Duplex kidneys appear as two separate collecting systems on the same side of the body.
–Scintigraphy may demonstrate reflux up the ureter in a nonfunctioning duplex kidney with ureteral duplication.
–The presence of a duplex kidney and ureteral duplication, suggested by excretory urographic or ultrasonographic images, can be confirmed with scintigraphy.
–The use of dimethyl succinic acid (DMSA) scanning to assess parenchymal function in
a duplex kidney is of great value in the management of duplex kidney.
•MR urography (Figs. 6.16, 6.17, 6.18, and 6.19):
–This may be used as a primary diagnostic method in assessing a duplex ectopic ureter and complications associated with duplex kidneys.
•An ectopic ureter extending from a poorly functioning moiety of a duplex kidney, invisible on other imaging, may be observed with MR urography
•Micturating cystourethrography:
–The intravesical ectopic ureter of a nonvisualized moiety is better demonstrated using voiding cystourethrogram.
–In patients with hydronephrosis, antegrade pyelography is useful for demonstrating the presence of a second ureter and for determining the level of termination.
6.4.5Treatment and Prognosis
•An asymptomatic duplex kidney usually does not require any treatment.
•Surgical treatment is indicated in the presence of complications.
•These complications include:
–Vesicoureteral reflux into lower pole moiety
–Marked hydronephrosis of the upper pole moiety may have mass effect or become infected
•Antibiotic prophylaxis is given to newborns with hydronephrosis or in patients who present with urinary tract infection (UTI) until the diagnosis is made and reflux is ruled out.
•Antibiotic prophylaxis is often continued in patients with obstructed systems and in infants with dilated nonobstructed systems.
•Duplicated collecting systems with reflux are managed conservatively with antibiotic prophylaxis until the reflux spontaneously
resolves or until the child is older (6–12 months), at which time surgery may be more easily accomplished.
196 |
6 Congenital Ureteral Anomalies |
|
|
Figs. 6.16, 6.17, 6.18, and 6.19 MRU showing bilateral duplex kidneys. Note the associated hydronephrosis and hydroureters
•In infants with duplicated systems and a wellfunctioning but obstructed upper-pole moiety or an obstructed ectopic single-system ureter, urinary diversion (A cutaneous ureterostomy) may be the treatment of choice until the bladder
is bigger and a ureteral reimplantation with or without ureteral tailoring is more feasible.
•In infants with a duplicated system and no reflux is present in the lower-pole system, a ureteroureterostomy is an option.